




Searching News Database: Osteocel
HSMN NewsFeed - 12 Jun 2018
NuVasive Launches AttraX Scaffold Biologic And Reports First Clinical Use
NuVasive Launches AttraX Scaffold Biologic And Reports First Clinical Use
HSMN NewsFeed - 8 May 2008
NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics
NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics
HSMN NewsFeed - 8 May 2008
Osiris Receives Approval for Use of Prochymal(TM) Under FDA Expanded Access Treatment Program
Osiris Receives Approval for Use of Prochymal(TM) Under FDA Expanded Access Treatment Program
HSMN NewsFeed - 7 Jan 2008
Osiris Therapeutics Regains Worldwide Rights to Cardiovascular Indications for Prochymal(TM)
Osiris Therapeutics Regains Worldwide Rights to Cardiovascular Indications for Prochymal(TM)
HSMN NewsFeed - 27 Nov 2007
Osiris Therapeutics Announces Positive One Year Data from Chondrogen Trial for Knee Repair
Osiris Therapeutics Announces Positive One Year Data from Chondrogen Trial for Knee Repair
HSMN NewsFeed - 9 Oct 2007
Osiris Therapeutics Secures $30 Million Financing Commitment from Chairman and Largest Shareholder
Osiris Therapeutics Secures $30 Million Financing Commitment from Chairman and Largest Shareholder
HSMN NewsFeed - 14 Aug 2006
Osiris Announces Expansion of Board of Directors and Key Additions to its Senior Management Team
Osiris Announces Expansion of Board of Directors and Key Additions to its Senior Management Team
HSMN NewsFeed - 10 Aug 2006
Blackstone Medical, Inc. Is Acquired by Orthofix International N.V. for US$ 333 Million
Blackstone Medical, Inc. Is Acquired by Orthofix International N.V. for US$ 333 Million
Additional items found! 1

Members Archive contains
1 additional stories matching:
Osteocel
(Password required)
Osteocel
(Password required)